MAPK3 and breast carcinoma: Our results demonstrated that resveratrol markedly decreased phosphorylated ERK1/2 and AKT levels in all tested breast cancer cells, consistent with a reduction in membrane phospholipid synthesis and subsequent disruption of lipid raft assembly and EGFR localization [48].